Open Access
CC BY 4.0 · Brazilian Journal of Oncology 2019; 15
DOI: 10.1055/s-0044-1797875
E-PÔSTER
TEMÁRIO: OUTROS E MISCELÂNIA

EXTRANEURAL METASTASIS OF AN EPENDYMOMA: A CASE REPORT

Sárgio Murilo Pereira da Silva Filho
1   Liga Acadêmica de Oncologia do Hospital de Base do Distrito Federal
,
Beatriz Pires Paes
1   Liga Acadêmica de Oncologia do Hospital de Base do Distrito Federal
,
Henrique Barbosa de Abreu
1   Liga Acadêmica de Oncologia do Hospital de Base do Distrito Federal
,
Beatriz Carneiro Habbema de Maia
1   Liga Acadêmica de Oncologia do Hospital de Base do Distrito Federal
,
Anna Paula de Sousa Silva
1   Liga Acadêmica de Oncologia do Hospital de Base do Distrito Federal
,
José Donato de Sousa Netto
1   Liga Acadêmica de Oncologia do Hospital de Base do Distrito Federal
,
Paulo Henrique Rodrigues Correia
1   Liga Acadêmica de Oncologia do Hospital de Base do Distrito Federal
,
Bruno José de Queiroz Sarmento
1   Liga Acadêmica de Oncologia do Hospital de Base do Distrito Federal
,
Rodrigo Nascimento Pinheiro
1   Liga Acadêmica de Oncologia do Hospital de Base do Distrito Federal
,
Fernanda Penna Lima Guedes de Amorim
1   Liga Acadêmica de Oncologia do Hospital de Base do Distrito Federal
› Author Affiliations

Case Report: A 36 - year old man, previously healthy. presented with intracranial hypertension syndrome: intense headache that started 2 months ago associated with convergent squint and diplopia. Brain MRI with contrast showed a right temporal parietal expansive lesion with a 12 mm deviation of the longitudinal fissure, subfalcine and transtentorial herniation, suggestive of high grade neoplasic lesion. The histopathological/ immunohistochemical diagnostic indicated a high grade glioma compatible with anaplastic ependymoma. Patient received adjuvant radiotherapy. 11 months after surgery, presented with intense pain in lumbar region with left leg irradiation and concomitant force reduction in the same member. Lumbar MRI showed diffuse infiltration of vertebras and tumoral extension to muscle. Abdominal CT scan also showed lesions in the pelvic bone. Finally, a biopsy of a lesion in the left iliac bone confirmed metastasis of the ependymoma. Discussion: Ependymomas are ependymal cells tumors, specific types of glial cells, originated from the neuroectoderm, that arise within or adjacent to the ependymal lining of the ventricular system . Ependymomas most commonly occur in the posterior fossa, in contact with the fourth ventricle, or in the intramedullary spinal cord, they ocasionally occur in the brain parenchya outside the posterior fossa, and very rarely outside the central nervous system (CNS). Ependymomas account for less 10 percent of tumors arising in the CNS. The metastatic occurrence is rare, nevertheless metastasis cases were described in adults in the following areas: lungs, cervical and hilar lymph nodes, skin, pleura, mediastinum, liver, diaphragm and bones. Final comments: Anaplastic ependymoma case was related, in which the chosen treatment was resection of the tumor associated with adjuvant therapy. The tumor evolved with metastasis to various locations with bone tissue, liver and muscle. The situation is a rare evolution to this type of tumor.



Publication History

Article published online:
23 October 2019

© 2019. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

Bibliographical Record
Sárgio Murilo Pereira da Silva Filho, Beatriz Pires Paes, Henrique Barbosa de Abreu, Beatriz Carneiro Habbema de Maia, Anna Paula de Sousa Silva, José Donato de Sousa Netto, Paulo Henrique Rodrigues Correia, Bruno José de Queiroz Sarmento, Rodrigo Nascimento Pinheiro, Fernanda Penna Lima Guedes de Amorim. EXTRANEURAL METASTASIS OF AN EPENDYMOMA: A CASE REPORT. Brazilian Journal of Oncology 2019; 15.
DOI: 10.1055/s-0044-1797875